PURLs

Dust mite control measures don’t help asthma patients

Author and Disclosure Information

Forget about mattress covers and air filtration systems. They don’t work, despite what the guidelines say.


 

References

ILLUSTRATIVE CASE

The parents of a 10-year-old patient whom you recently diagnosed with asthma want to do everything they can to reduce his asthma symptoms. They are considering buying hypoallergenic mattress covers and an expensive air filtration system to decrease the levels of dust mite allergens in their home and want to know if you think that will help their son. What do you tell them?

We want to do everything we can to help our patients control their asthma symptoms, but when it comes to household dust mite control measures, this extensive Cochrane review confirms that interventions like mattress covers and air filtration don’t work, despite recent reviews and guidelines recommending them.

Dust mites (Dermatophagoides pteronyssinus) are one of the most common allergens that provoke asthma symptoms in children and adults.2 Dust mites live in warm, humid places and feed on human skin scales. The areas with the highest levels of household infestation are carpets, mattresses, pillows, drapes, upholstered furniture, and clothing.

Guidelines still encourage mattress cover use

The National Asthma Education and Prevention Program (NAEPP) 2007 guidelines recommend using allergen-impermeable mattress and pillow covers and washing sheets and blankets in hot water. They also recommend “considering” reducing indoor humidity, removing bedroom carpets, and washing stuffed toys weekly. The NAEPP Expert Panel cites many studies to support these recommendations.3

The National Environmental Education and Training Foundation (NEETF) 2005 guidelines recommend additional measures to reduce dust mite exposure including vacuuming using a high-efficiency particulate air (HEPA) filter, removing draperies, and considering using a portable air cleaner with a HEPA filter.4

STUDY SUMMARY: 54 trials, but no support for dust mite measures

This Cochrane systematic review included 54 randomized trials that assessed the effects of physical and/or chemical interventions to reduce exposure to house dust mite antigens in the homes of patients with mite-sensitive asthma. These studies included a total of 3002 pediatric and adult asthma patients (9 - 628 patients analyzed per trial) with mite sensitization confirmed by skin testing or IgE serum assays.

Thirty-six studies tested physical interventions, including mattress covers, vacuum cleaning, heating, ventilation, freezing, washing, air filtration, and ionizers. Ten used chemical interventions to kill dust mites; 8 used a combination of physical and chemical methods. Control groups received either placebo or no treatment.

Outcomes studied. The authors extracted data for the following outcomes: subjective well-being, asthma symptom scores, use of medication, days of sick leave from school or work, number of unscheduled visits to a physician or hospital, forced expiratory volume in 1 second (FEV1), peak expiratory flow rate (PEFR), and provocative concentration that causes a 20% fall in FEV1 (PC20). Length of the intervention and follow-up ranged from 2 weeks to 2 years.

Quality of studies. According to modern standards for randomized trials, the quality of many of the 54 studies was not optimal, especially in the descriptions of randomization and the reporting of outcomes. The method of randomization and concealment of allocation was rarely described. Eleven trial reports did not contain any usable data for the meta-analysis because of the way data were reported, and there was significant potential for reporting bias in favor of a treatment effect in the studies included. Mite reduction was successful in 17 trials, unsuccessful in 24 trials, and not reported in 13 trials.

Interventions didn’t help. There were no differences between the intervention and control groups for any of the outcomes. The percentage of patients who improved after the experimental interventions was not significantly different from the percentage of patients in the control groups (relative risk [RR]=1.01; 95% confidence interval [CI], 0.80-1.27; data based on 7 trials). There was no difference in medication usage (data from 10 trials), FEV1 (data from 14 trials), morning PEFR (data from 23 trials), or PC 20 (data from 14 trials) between the intervention and control groups ( TABLE ).1

TABLE
Dust mite control measures didn’t improve these outcomes

OUTCOMESTANDARDIZED MEAN DIFFERENCE* (95% CI)
Medication usage-0.06 (-0.18 to 0.07)
FEV10.11 (-0.05 to 0.28)
Morning PEFR0.00 (-1.0 to 0.10)
PC 200.05 (-0.13 to 0.22)
CI, confidence interval; FEV1, forced expiratory volume in 1 second; PC20, provocative concentration that causes a 20% fall in FEV1; PEFR, peak expiratory flow rate.
*Standardized mean difference is a common way to combine results of different studies for comparison purposes. If the 95% CI crosses 0, there is no effect of the intervention compared with the control.

Pages

Copyright © 2008 The Family Physicians Inquiries Network.
All rights reserved.

Online-Only Materials

AttachmentSize
PDF icon JFP05712789_methodology49.23 KB

Recommended Reading

Are inhalers with spacers better than nebulizers for children with asthma?
MDedge Family Medicine
How effective are leukotriene inhibitors for asthma in children?
MDedge Family Medicine
Is nedocromil effective in preventing asthmatic attacks in patients with asthma?
MDedge Family Medicine
What best prevents exercise-induced bronchoconstriction for a child with asthma?
MDedge Family Medicine
What is the preferred treatment for a child with mild persistent asthma?
MDedge Family Medicine
Are any alternative therapies effective in treating asthma?
MDedge Family Medicine
Help patients gain better asthma control
MDedge Family Medicine
Changes in recommended treatments for mild and moderate asthma
MDedge Family Medicine
Educational interventions improve outcomes for children with asthma
MDedge Family Medicine
High-dose zafirlukast in emergency department provides small benefit in acute asthma
MDedge Family Medicine